Brain stimulation plus talk therapy for insomnia in mild cognitive impairment
Tests magnetic brain stimulation with sleep therapy in people with mild cognitive impairment and insomnia.
Key facts
- Who runs it
- Beth Israel Deaconess Medical Center
- Where
- Boston, United StatesSee the site
- Trial code
- Registry title
- Treating Insomnia in Mild Cognitive Impairment
- Status
- Recruiting
- People taking part
- 30 people, planned
- Started
- 1 May 2025
- Expected to end
- 30 Jun 2028
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Transcranial Magnetic Stimulation (TMS) therapy
- Cognitive behavioral therapy for insomnia (CBT-I)
- Record updated
- 5 November 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people aged 60 or older with mild cognitive impairment (MCI) or subjective cognitive impairment, who also have insomnia. It tests brain stimulation (TMS) combined with talk therapy for insomnia (CBT-I).
- Age
- 60 Years or older
- Sex
- All
- Disease stage
- A clinical diagnosis of MCI or subjective cognitive impairment (a felt, gradual worsening of thinking ability). Insomnia symptoms (trouble falling or staying asleep) causing significant distress or problems in daily life over the past three months.
- Earlier treatment
- People currently getting psychological treatment for insomnia cannot join.
Main reasons for not taking part
- Significant cognitive impairment or dementia
- Reasons you cannot have TMS or MRI
- Uncontrolled moderate-to-severe obstructive sleep apnea or another untreated sleep disorder (managed sleep apnea stable for ≥3 months is allowed)
- Parkinson's disease, Huntington's disease, Lewy-Body disease or another neurological condition that affects sleep
- Current major psychiatric disorder, current opiate/opioid use, or alcohol or drug abuse within the past year
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- Aged 60 years or older
- Speak and read English
- Clinical diagnosis of MCI or Subjective Cognitive Impairment (SCI)-a perceived gradual worsening in cognitive ability relative to one's younger self, or peer group-reported by either the participant or informant
- Reported insomnia symptoms (sleep-onset and/or sleep maintenance) that cause significant distress or impairment in social, occupational, or other areas of functioning over the past three months
- Have access to an Internet-enabled computer or tablet at home, or ability to connect a BIDMC-provided tablet to the internet, with private space to complete cognitive testing
- Capable of and willing to provide written informed consent
Who cannot take part
- Alcohol or drug abuse within the past year
- Evidence of significant cognitive impairment or dementia
- Uncontrolled moderate-to-severe obstructive sleep apnea or other untreated sleep disorder (e.g., Restless Leg Syndrome, Periodic Limb Movement Disorder, parasomnia). Sleep apnea that is managed (e.g., regular use of a CPAP) and stable for ≥3 months is allowed
- Diagnosis of Parkinson's disease, Huntington's disease, Lewy-Body disease, or other neurological condition known to impact sleep
- Current diagnosis of major psychiatric disorder (well-controlled depression or anxiety is permitted)
- Contraindications for TMS or MRI
- Current psychological treatment for insomnia
- Current opiate/opioid use
- Irregular sleep schedule (bedtime before 8pm/after 2am OR wake time before 4am/after 10am), unless participant states they are willing and able to change if prompted
Where in United States
- Beth Israel Deaconess Medical CenterBoston, United StatesContact: Alex Clinical Research CoordinatorTaking people
About the trial
What the trial wants to find out
The goal of this study is to test a new way to improve sleep quality in persons living with mild cognitive impairment. The treatment combines a safe and gentle way to stimulate the brain, called transcranial magnetic stimulation, with a psychological treatment, called cognitive behavioral therapy for insomnia.
The 2 groups in the trial
- One (1) TMS treatment per day plus CBT-IExisting treatment, for comparison
One (1) daily treatment of intermittent theta-burst stimulation (iTBS) applied to the left dorsolateral prefrontal cortex (L-DLPFC) for 10 days (2 weeks) followed by a 9-week Internet-delivered cognitive behavioral therapy for insomnia (CBT-I) program
Treatment: Transcranial Magnetic Stimulation (TMS) therapy and Cognitive behavioral therapy for insomnia (CBT-I)
- Two (2) TMS treatments per day plus CBT-IExisting treatment, for comparison
Two (2) daily treatments, spaced 1 hour apart, of intermittent theta-burst stimulation (iTBS) applied to the left dorsolateral prefrontal cortex (L-DLPFC) for 10 days (2 weeks) followed by a 9-week Internet-delivered cognitive behavioral therapy for insomnia (CBT-I) program
Treatment: Transcranial Magnetic Stimulation (TMS) therapy and Cognitive behavioral therapy for insomnia (CBT-I)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Neuromodulation and Cognitive Behavioral Therapy for Insomnia in MCI
- Plain-language title
- Brain stimulation plus talk therapy for insomnia in mild cognitive impairmentGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Publications
- Treating insomnia in mild cognitive impairment: a novel approach combining transcranial magnetic stimulation with cognitive behavioral therapy.International review of psychiatry (Abingdon, England), 2026
- Record updated
- 5 November 2026